Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Poole

Showing results (201-210 of 302) with videos related to

Pageof 31
Sort By:
Circulation|August 1, 1991
Electrode system influence on biphasic waveform defibrillation efficacy in humansG H Bardy, C Troutman, G Johnson, et al.
Journal of the American College of Cardiology|September 1, 1990
Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroupsJ E Poole, T L Mathisen, P J Kudenchuk, et al.
Annals of Emergency Medicine|August 1, 1997
Biphasic transthoracic defibrillation causes fewer ECG ST-segment changes after shockR K Reddy, M J Gleva, B E Gliner, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1995
Anatomical findings in patients having had a chronically indwelling coronary sinus defibrillation leadG K Jones, C Swerdlow, D D Reichenbach, et al.
Circulation|April 1, 1993
Implantable transvenous cardioverter-defibrillatorsG H Bardy, B Hofer, G Johnson, et al.
American Heart Journal|June 2, 2024
Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50Lee B Bockus, Ramin Shadman, Jeanne E Poole, et al.
Circulation|August 1, 1993
A simplified, single-lead unipolar transvenous cardioversion-defibrillation systemG H Bardy, G Johnson, J E Poole, et al.
Journal of Cardiovascular Electrophysiology|March 1, 1996
Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugsG L Dolack, J E Poole, P J Kudenchuk, et al.
JAMA Cardiology|July 21, 2017
Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure TrialSelcuk Adabag, Kristen K Patton, Alfred E Buxton, et al.
Circulation|October 29, 2008
Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudyMichael R Gold, John H Ip, Otto Costantini, et al.
Pageof 31

Showing results (201-210 of 302) with videos related to

Sort By:
Pageof 31
Circulation|August 1, 1991
Electrode system influence on biphasic waveform defibrillation efficacy in humansG H Bardy, C Troutman, G Johnson, et al.
Journal of the American College of Cardiology|September 1, 1990
Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroupsJ E Poole, T L Mathisen, P J Kudenchuk, et al.
Annals of Emergency Medicine|August 1, 1997
Biphasic transthoracic defibrillation causes fewer ECG ST-segment changes after shockR K Reddy, M J Gleva, B E Gliner, et al.
Pacing and Clinical Electrophysiology : PACE|November 1, 1995
Anatomical findings in patients having had a chronically indwelling coronary sinus defibrillation leadG K Jones, C Swerdlow, D D Reichenbach, et al.
Circulation|April 1, 1993
Implantable transvenous cardioverter-defibrillatorsG H Bardy, B Hofer, G Johnson, et al.
American Heart Journal|June 2, 2024
Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50Lee B Bockus, Ramin Shadman, Jeanne E Poole, et al.
Circulation|August 1, 1993
A simplified, single-lead unipolar transvenous cardioversion-defibrillation systemG H Bardy, G Johnson, J E Poole, et al.
Journal of Cardiovascular Electrophysiology|March 1, 1996
Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugsG L Dolack, J E Poole, P J Kudenchuk, et al.
JAMA Cardiology|July 21, 2017
Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure TrialSelcuk Adabag, Kristen K Patton, Alfred E Buxton, et al.
Circulation|October 29, 2008
Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudyMichael R Gold, John H Ip, Otto Costantini, et al.
Pageof 31